http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109316485-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-80
filingDate 2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109316485-B
titleOfInvention Anti-tumor application of covalent organic framework material
abstract The invention provides application of a covalent organic framework material in preparation of one or more of tumor treatment drugs, photodynamic therapy drugs and photothermal therapy drugs; the covalent organic framework material has a structure shown in a formula (I). The covalent organic framework material with the structure of formula (I) is used in medicaments for treating tumors, medicaments for photodynamic therapy and medicaments for photothermal therapy, can release heat after light excitation, thereby realizing the photothermal therapy of tumors, and can realize the synergistic therapy of photodynamic and photothermal under single wavelength, thereby realizing powerful killing of cells. In addition, the invention also finds that the covalent organic framework material has an EPR effect, improves the enrichment of the nanosheet in an in vivo experiment, has the photoacoustic imaging capability, and can determine the optimal enrichment time of the covalent organic framework material, thereby realizing tumor treatment under the guidance of imaging.
priorityDate 2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161959906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454286746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415709274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414284734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7076

Total number of triples: 30.